Oxiquim Past Earnings Performance
Past criteria checks 4/6
Oxiquim has been growing earnings at an average annual rate of 14.8%, while the Chemicals industry saw earnings growing at 18.2% annually. Revenues have been growing at an average rate of 11.9% per year. Oxiquim's return on equity is 22.2%, and it has net margins of 11.1%.
Key information
14.8%
Earnings growth rate
14.7%
EPS growth rate
| Chemicals Industry Growth | 13.1% |
| Revenue growth rate | 11.9% |
| Return on equity | 22.2% |
| Net Margin | 11.1% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Oxiquim's (SNSE:OXIQUIM) Shareholders May Want To Dig Deeper Than Statutory Profit
Apr 07
Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?
Jun 10Are Dividend Investors Making A Mistake With Oxiquim S.A. (SNSE:OXIQUIM)?
Apr 22Returns At Oxiquim (SNSE:OXIQUIM) Appear To Be Weighed Down
Apr 01Oxiquim S.A.'s (SNSE:OXIQUIM) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Mar 11Is Oxiquim (SNSE:OXIQUIM) Using Too Much Debt?
Feb 18Did You Participate In Any Of Oxiquim's (SNSE:OXIQUIM) Incredible 355% Return?
Jan 27
Has Oxiquim (SNSE:OXIQUIM) Got What It Takes To Become A Multi-Bagger?
Dec 28Oxiquim S.A. (SNSE:OXIQUIM) On An Uptrend: Could Fundamentals Be Driving The Stock?
Dec 07Revenue & Expenses BreakdownBeta
How Oxiquim makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 214,649 | 23,896 | 41,921 | 0 |
| 30 Sep 23 | 221,904 | 24,930 | 42,204 | 0 |
| 30 Jun 23 | 243,733 | 27,088 | 43,357 | 0 |
| 31 Mar 23 | 258,547 | 27,220 | 43,386 | 0 |
| 31 Dec 22 | 264,695 | 29,252 | 42,902 | 0 |
| 30 Sep 22 | 262,663 | 28,624 | 41,367 | 0 |
| 30 Jun 22 | 238,874 | 25,710 | 38,470 | 0 |
| 31 Mar 22 | 213,134 | 24,850 | 35,558 | 0 |
| 31 Dec 21 | 191,128 | 20,727 | 33,870 | 0 |
| 30 Sep 21 | 170,947 | 18,471 | 41,233 | 0 |
| 30 Jun 21 | 161,252 | 18,276 | 37,019 | 0 |
| 31 Mar 21 | 155,708 | 16,972 | 34,251 | 0 |
| 31 Dec 20 | 158,135 | 17,219 | 31,036 | 0 |
| 30 Sep 20 | 158,113 | 16,720 | 17,762 | 0 |
| 30 Jun 20 | 155,569 | 15,368 | 17,889 | 0 |
| 31 Mar 20 | 155,075 | 15,874 | 16,592 | 0 |
| 31 Dec 19 | 152,021 | 15,618 | 16,199 | 0 |
| 30 Sep 19 | 154,655 | 14,770 | 17,053 | 0 |
| 30 Jun 19 | 157,881 | 16,018 | 17,294 | 0 |
| 31 Mar 19 | 158,870 | 15,263 | 17,153 | 0 |
| 31 Dec 18 | 156,502 | 14,302 | 17,219 | 0 |
| 30 Sep 18 | 151,351 | 13,534 | 16,953 | 0 |
| 30 Jun 18 | 146,847 | 12,685 | 16,481 | 0 |
| 31 Mar 18 | 145,208 | 18,055 | 17,131 | 0 |
| 31 Dec 17 | 144,253 | 18,294 | 17,078 | 0 |
| 30 Sep 17 | 141,722 | 21,842 | 16,111 | 0 |
| 30 Jun 17 | 138,877 | 21,562 | 15,973 | 0 |
| 31 Mar 17 | 135,566 | 16,033 | 15,271 | 0 |
| 31 Dec 16 | 134,438 | 16,492 | 14,998 | 0 |
| 30 Sep 16 | 136,729 | 13,242 | 14,987 | 0 |
| 30 Jun 16 | 140,238 | 13,054 | 15,005 | 0 |
| 31 Mar 16 | 142,591 | 12,493 | 15,002 | 0 |
| 31 Dec 15 | 144,059 | 12,013 | 14,891 | 0 |
| 30 Sep 15 | 144,708 | 10,554 | 14,940 | 0 |
| 30 Jun 15 | 142,750 | 9,386 | 14,199 | 0 |
| 31 Mar 15 | 140,734 | 9,598 | 13,663 | 0 |
| 31 Dec 14 | 140,119 | 8,592 | 13,245 | 0 |
| 30 Sep 14 | 128,174 | 8,715 | 10,506 | 0 |
| 30 Jun 14 | 129,377 | 7,667 | 11,122 | 0 |
| 31 Mar 14 | 134,570 | 6,195 | 11,700 | 0 |
| 31 Dec 13 | 133,314 | 5,392 | 11,600 | 0 |
Quality Earnings: OXIQUIM has high quality earnings.
Growing Profit Margin: OXIQUIM's current net profit margins (11.1%) are higher than last year (11.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OXIQUIM's earnings have grown by 14.8% per year over the past 5 years.
Accelerating Growth: OXIQUIM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: OXIQUIM had negative earnings growth (-18.3%) over the past year, making it difficult to compare to the Chemicals industry average (-33%).
Return on Equity
High ROE: OXIQUIM's Return on Equity (22.2%) is considered high.